Post by Andreas Zumbuehl
Head of Scientific & Corporate Development @ InnoMedica | Biotech Business Development, Licensing & IP Strategy in Nanomedicine | I turn clinical data into partner-ready, financeable assets
What happens when a scientist becomes a Parkinson’s patient himself? At the age of 30, Guillaume Brachet is diagnosed with Parkinson’s disease. Rather than accepting the limits of existing answers, he begins to explore the disease through the lens of scientific research. His search for new therapeutic approaches eventually takes him from reading scientific papers to founding his own biotech company. In Parkinson à 30 ans, he recounts this remarkable journey at the intersection of personal experience, research, and entrepreneurship. https://lnkd.in/eUij_v5g
